Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma

References

• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• HeimbachJKKulikLMFinnRSAASLD guidelines for the treatment of hepatocellular carcinomaHepatology201867135838028130846
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the LiverElectronic address: [email protected]; European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol201869118223629628281
   PubMed Web of Science ®Google Scholar
• OmataMChengALKokudoNAsia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateHepatol Int201711431737028620797
   PubMed Web of Science ®Google Scholar
• ZhongJHKeYGongWFHepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinomaAnn Surg2014260232934024096763
   PubMed Web of Science ®Google Scholar
• HernaezRSolàEMoreauRGinèsPAcute-on-chronic liver failure: an updateGut201766354155328053053
   PubMed Web of Science ®Google Scholar
• SchreckenbachTLieseJBechsteinWOMoenchCPosthepatectomy liver failureDig Surg2012291798522441624
   PubMed Web of Science ®Google Scholar
• RahbariNNGardenOJPadburyRPosthepatectomy liver failure: a definition and grading by the International Study Group of liver surgery (ISGLS)Surgery2011149571372421236455
   PubMed Web of Science ®Google Scholar
• MelloulEHübnerMScottMGuidelines for perioperative care for liver surgery: enhanced recovery after surgery (ERAS) Society recommendationsWorld J Surg201640102425244027549599
   PubMed Web of Science ®Google Scholar
• DurandFVallaDAssessment of the prognosis of cirrhosis: childpugh versus MELDJ Hepatol2005421S100S10715777564
   PubMedGoogle Scholar
• MalinchocMKamathPSGordonFDPeineCJRankJter BorgPCA model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shuntsHepatology200031486487110733541
   PubMed Web of Science ®Google Scholar
• KamathPSWiesnerRHMalinchocMA model to predict survival in patients with end-stage liver diseaseHepatology200133246447011172350
   PubMed Web of Science ®Google Scholar
• WiesnerREdwardsEFreemanRModel for end-stage liver disease (MELD) and allocation of donor liversGastroenterology20031241919612512033
   PubMed Web of Science ®Google Scholar
• JohnsonPJBerhaneSKagebayashiCAssessment of liver function in patients with hepatocellular carcinoma: a new evidence-based Approach—the ALBI gradeJ Clin Oncol201533655055825512453
   PubMed Web of Science ®Google Scholar
• WaiCA simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CHepatology200338251852612883497
   PubMed Web of Science ®Google Scholar
• ChanAWChanRCWongGLNew simple prognostic score for primary biliary cirrhosis: albumin-bilirubin scoreJ Gastroenterol Hepatol20153091391139625753927
   PubMed Web of Science ®Google Scholar
• WangYYZhongJHSuZYAlbumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinomaBr J Surg2016103672573427005482
   PubMed Web of Science ®Google Scholar
• ChenRCCaiYJWuJMUsefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosisJ Viral Hepat201724323824527862671
   PubMed Web of Science ®Google Scholar
• LinZHXinYNDongQJPerformance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysisHepatology201153372673621319189
   PubMed Web of Science ®Google Scholar
• ShihaGIbrahimAHelmyAAsian-Pacific association for the study of the liver (APASL) consensus Guidelines on invasive and noninvasive assessment of hepatic fibrosis: a 2016 updateHepatol Int2017111130
   PubMed Web of Science ®Google Scholar
• BruixJReigMShermanMEvidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinomaGastroenterology2016150483585326795574
   PubMed Web of Science ®Google Scholar
• HermanekPWittekindCThe pathologist and the residual tumor (R) classificationPathol Res Pract199419021151238058567
   PubMed Web of Science ®Google Scholar
• PolBCampanPHardwigsenJBottiGPonsJLe TreutYPMorbidity of major hepatic resections: a 100-case prospective studyEur J Surg1999165544645310391161
   PubMedGoogle Scholar
• BerzigottiAReigMAbraldesJGBoschJBruixJPortal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysisHepatology201561252653625212123
   PubMed Web of Science ®Google Scholar
• HuangGLauWYShenFPreoperative hepatitis B virus DNA level is a risk factor for postoperative liver failure in patients who underwent partial hepatectomy for hepatitis B-related hepatocellular carcinomaWorld J Surg20143892370237624696061
   PubMed Web of Science ®Google Scholar
• AnHJJangJWBaeSHSustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinomaJ Gastroenterol Hepatol201025121876188221092000
   PubMed Web of Science ®Google Scholar
• HungIFPoonRTLaiCLFungJFanSTYuenMFRecurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resectionAm J Gastroenterol200810371663167318616655
   PubMed Web of Science ®Google Scholar
• WebsterGIncubation phase of acute hepatitis B in man: dynamic of cellular immune mechanismsHepatology20003251117112411050064
   PubMed Web of Science ®Google Scholar
• XiaoGYangJYanLComparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysisHepatology201561129230225132233
   PubMed Web of Science ®Google Scholar
• RösslerFSapisochinGSongGDefining benchmarks for major liver surgery: a multicenter analysis of 5202 living liver donorsAnn Surg2016264349250027433909
   PubMed Web of Science ®Google Scholar
• CywinskiJBAlsterJMMillerCVogtDPParkerBMPrediction of intraoperative transfusion requirements during orthotopic liver transplantation and the influence on postoperative patient survivalAnesth Analg2014118242843724445640
   PubMed Web of Science ®Google Scholar
• OkudaMLiKBeardMRMitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core proteinGastroenterology2002122236637511832451
   PubMed Web of Science ®Google Scholar
• FreedmanRADockterTJLafkyJMPromoting accrual of older patients with cancer to clinical trials: an Alliance for clinical trials in oncology member Survey (A171602)Oncologist20182391016102329674441
   PubMed Web of Science ®Google Scholar
• McCormickPAMurphyKMSplenomegalyMKMSplenomegaly, hypersplenism and coagulation abnormalities in liver diseaseBaillieres Best Pract Res Clin Gastroenterol20001461009103111139352
   PubMed Web of Science ®Google Scholar
• KurokawaTMurataSOhkohchiNStable liver function during long-term administration of eltrombopag, a thrombopoietin receptor agonist, in patients with chronic liver diseaseTohoku J Exp Med2016240427727927928110
   PubMed Web of Science ®Google Scholar
• MaithelSKKneuertzPJKoobyDAImportance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysisJ Am Coll Surg2011212463864821463803
   PubMed Web of Science ®Google Scholar